GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elixinol Wellness Ltd (ASX:EXL) » Definitions » Enterprise Value

Elixinol Wellness (ASX:EXL) Enterprise Value : A$5.76 Mil (As of May. 12, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Elixinol Wellness Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Elixinol Wellness's Enterprise Value is A$5.76 Mil. Elixinol Wellness's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-7.44 Mil. Therefore, Elixinol Wellness's EV-to-EBIT ratio for today is -0.77.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Elixinol Wellness's Enterprise Value is A$5.76 Mil. Elixinol Wellness's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was A$-6.84 Mil. Therefore, Elixinol Wellness's EV-to-EBITDA ratio for today is -0.84.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Elixinol Wellness's Enterprise Value is A$5.76 Mil. Elixinol Wellness's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was A$8.27 Mil. Therefore, Elixinol Wellness's EV-to-Revenue ratio for today is 0.70.


Elixinol Wellness Enterprise Value Historical Data

The historical data trend for Elixinol Wellness's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elixinol Wellness Enterprise Value Chart

Elixinol Wellness Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial 62.12 29.75 12.80 5.68 8.15

Elixinol Wellness Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.80 1.48 5.68 4.18 8.15

Competitive Comparison of Elixinol Wellness's Enterprise Value

For the Drug Manufacturers - Specialty & Generic subindustry, Elixinol Wellness's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elixinol Wellness's Enterprise Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elixinol Wellness's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Elixinol Wellness's Enterprise Value falls into.



Elixinol Wellness Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Elixinol Wellness's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Elixinol Wellness's Enterprise Value for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Elixinol Wellness  (ASX:EXL) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Elixinol Wellness's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=5.758/-7.436
=-0.77

Elixinol Wellness's current Enterprise Value is A$5.76 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Elixinol Wellness's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-7.44 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Elixinol Wellness's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=5.758/-6.839
=-0.84

Elixinol Wellness's current Enterprise Value is A$5.76 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Elixinol Wellness's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was A$-6.84 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Elixinol Wellness's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=5.758/8.269
=0.70

Elixinol Wellness's current Enterprise Value is A$5.76 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Elixinol Wellness's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was A$8.27 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Elixinol Wellness Enterprise Value Related Terms

Thank you for viewing the detailed overview of Elixinol Wellness's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Elixinol Wellness (ASX:EXL) Business Description

Traded in Other Exchanges
Address
680 George Street, Level 12, Sydney, NSW, AUS, 2000
Elixinol Wellness Ltd is engaged in the hemp industry, innovating, marketing, and selling hemp-derived nutraceutical, cosmetic, and food products. It operates in the geographical segments of the Americas, Australia, Europe and other regions of which key revenue is derived from the Americas segment. The Americas segment includes the trading results of Elixinol LLC (Elixinol Americas) and its investments and joint ventures in the US through the manufacture and distribution of hemp-derived cannabidiol products.

Elixinol Wellness (ASX:EXL) Headlines

No Headlines